X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/09/25/2748856/0/en/National-Institute-of-Health-to-Fund-Preclinical-Development-of-Trethera-Lead-Drug-TRE-515-for-Treatment-of-Crohn-s-Disease.html
https://www.globenewswire.com//news-release/2023/09/05/2737597/0/en/Globally-Recognized-Expert-in-Rare-Neurologic-Diseases-Dr-Michael-Levy-Joins-Trethera-Scientific-Advisory-Board.html
https://www.globenewswire.com/news-release/2023/08/14/2724752/0/en/Trethera-Receives-NIH-Grant-for-Preclinical-Development-in-the-Pediatric-Neurologic-Disease-Acute-Disseminated-Encephalomyelitis.html
https://www.globenewswire.com/news-release/2023/03/15/2627997/0/en/Dose-Escalation-Portion-of-Phase-1-Solid-Tumors-Trial-Produces-Favorable-Results-in-Heavily-Pretreated-Solid-Tumor-Patients.html
https://www.globenewswire.com/news-release/2023/02/15/2608972/0/en/Trethera-Announces-Appointment-of-Laurent-Dubois-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/01/24/2594617/0/en/Trethera-Announces-Poster-Presentation-at-the-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-Annual-Meeting.html
https://www.globenewswire.com/news-release/2023/01/18/2591224/0/en/Trethera-Announces-Appointment-of-R-Boyd-Quinnell-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2022/10/19/2537742/0/en/Trethera-Receives-1-6-Million-National-Eye-Institute-Grant-for-Continued-Advancement-of-TRE-515-Optic-Neuritis-Program.html
https://www.globenewswire.com/news-release/2022/10/04/2528144/0/en/Trethera-Announces-Multiple-Sclerosis-Treatment-Poster-Presentation-at-the-American-Neurological-Association-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/09/20/2519592/0/en/U-S-Patent-Office-Issues-Trethera-Composition-of-Matter-Patent-Covering-TRE-515-Extending-Market-Exclusivity-to-Late-2041.html
Market Place
Share 
